Randomised, multicentre, placebo-controlled trial of fenofibrate for treatment of diabetic macular oedema with economic evaluation (FORTE study): study protocol for a randomised control trial. [PDF]
Nguyen H +4 more
europepmc +1 more source
Cost-Effectiveness of Faricimab in the Treatment of Diabetic Macular Oedema (DMO): A UK Analysis. [PDF]
Bührer C +4 more
europepmc +1 more source
Visual Acuity Outcomes and Influencing Factors in a Cohort of UK Real-World Diabetic Macular Oedema Patients During the First Two Years of Anti-VEGF Treatment. [PDF]
Wen Q +9 more
europepmc +1 more source
The impact of Vitreo-Macular interface abnormalities on the response to Anti-VEGF therapy for centre involving diabetic macular oedema. [PDF]
Maguire M +3 more
europepmc +1 more source
Economic Assessment in Resource-Constrained Systems: Individual-Level Simulation Model in Wet Age-Related Macular Degeneration and Diabetic Macular Oedema. [PDF]
Li T +7 more
europepmc +1 more source
Exploring the role of retinal fluid as a biomarker for the management of diabetic macular oedema. [PDF]
Khoramnia R +7 more
europepmc +1 more source
Levosulpiride for the treatment of diabetic macular oedema: a phase 2 randomized clinical trial. [PDF]
Núñez-Amaro CD +18 more
europepmc +1 more source
Faricimab for neovascular age-related macular degeneration and diabetic macular oedema. [PDF]
europepmc +1 more source

